OliX PharmaceuticalsI (Korea) Performance
| 226950 Stock | 19,620 630.00 3.11% |
On a scale of 0 to 100, OliX PharmaceuticalsI holds a performance score of 3. The company holds a Beta of 1.17, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OliX PharmaceuticalsI will likely underperform. Please check OliX PharmaceuticalsI's mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether OliX PharmaceuticalsI's historical price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in OliX PharmaceuticalsInc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, OliX PharmaceuticalsI sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | 15.5 B |
OliX |
OliX PharmaceuticalsI Relative Risk vs. Return Landscape
If you would invest 1,900,000 in OliX PharmaceuticalsInc on September 20, 2024 and sell it today you would earn a total of 62,000 from holding OliX PharmaceuticalsInc or generate 3.26% return on investment over 90 days. OliX PharmaceuticalsInc is generating 0.329% of daily returns and assumes 7.6241% volatility on return distribution over the 90 days horizon. Simply put, 67% of stocks are less volatile than OliX, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
OliX PharmaceuticalsI Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OliX PharmaceuticalsI's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OliX PharmaceuticalsInc, and traders can use it to determine the average amount a OliX PharmaceuticalsI's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0432
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 226950 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.62 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average OliX PharmaceuticalsI is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OliX PharmaceuticalsI by adding it to a well-diversified portfolio.
OliX PharmaceuticalsI Fundamentals Growth
OliX Stock prices reflect investors' perceptions of the future prospects and financial health of OliX PharmaceuticalsI, and OliX PharmaceuticalsI fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OliX Stock performance.
| Return On Equity | -76.63 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (6.56) % | |||
| Current Valuation | 576.53 B | |||
| Shares Outstanding | 6.51 M | |||
| Price To Sales | 75.58 X | |||
| Revenue | 3.67 B | |||
| EBITDA | (15.1 B) | |||
| Cash And Equivalents | 34.34 B | |||
| Total Debt | 20.38 B | |||
| Cash Flow From Operations | (19.05 B) | |||
| Total Asset | 86.67 B | |||
About OliX PharmaceuticalsI Performance
By analyzing OliX PharmaceuticalsI's fundamental ratios, stakeholders can gain valuable insights into OliX PharmaceuticalsI's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if OliX PharmaceuticalsI has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OliX PharmaceuticalsI has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about OliX PharmaceuticalsInc performance evaluation
Checking the ongoing alerts about OliX PharmaceuticalsI for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OliX PharmaceuticalsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OliX PharmaceuticalsI had very high historical volatility over the last 90 days | |
| The company reported the revenue of 3.67 B. Net Loss for the year was (30.28 B) with profit before overhead, payroll, taxes, and interest of 2.42 B. | |
| OliX PharmaceuticalsInc has accumulated about 34.34 B in cash with (19.05 B) of positive cash flow from operations. | |
| Roughly 29.0% of the company shares are owned by insiders or employees |
- Analyzing OliX PharmaceuticalsI's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OliX PharmaceuticalsI's stock is overvalued or undervalued compared to its peers.
- Examining OliX PharmaceuticalsI's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OliX PharmaceuticalsI's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OliX PharmaceuticalsI's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OliX PharmaceuticalsI's stock. These opinions can provide insight into OliX PharmaceuticalsI's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for OliX Stock analysis
When running OliX PharmaceuticalsI's price analysis, check to measure OliX PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OliX PharmaceuticalsI is operating at the current time. Most of OliX PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of OliX PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OliX PharmaceuticalsI's price. Additionally, you may evaluate how the addition of OliX PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |